Blackstone Inc’s Pliant Therapeutics PLRX Stock Holding History

Blackstone Inc’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.3K	Hold	22,206	–	–	﹤0.01%	518
2026 Q1	$28K	Hold	22,206	–	–	﹤0.01%	417
2025 Q4	$27.1K	Hold	22,206	–	–	﹤0.01%	245
2025 Q3	$32.9K	Hold	22,206	–	–	﹤0.01%	247
2025 Q2	$25.8K	Hold	22,206	–	–	﹤0.01%	168
2025 Q1	$30K	Hold	22,206	–	–	﹤0.01%	170
2024 Q4	$292K	Hold	22,206	–	–	﹤0.01%	152
2024 Q3	$249K	Hold	22,206	–	–	﹤0.01%	153
2024 Q2	$239K	Hold	22,206	–	–	﹤0.01%	165
2024 Q1	$331K	Hold	22,206	–	–	﹤0.01%	158
2023 Q4	$402K	Hold	22,206	–	–	﹤0.01%	142
2023 Q3	$385K	Hold	22,206	–	–	﹤0.01%	140
2023 Q2	$402K	Buy	22,206 +5,932	+36%	+$140K	﹤0.01%	139
2023 Q1	$433K	Hold	16,274	–	–	﹤0.01%	141
2022 Q4	$315K	Buy	16,274 +6,234	+62%	+$130K	﹤0.01%	146
2022 Q3	$210K	Buy	+10,040	New	+$192K	﹤0.01%	192

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Blackstone Inc's PLRX Position: Q2 2026 in Review

Blackstone Inc held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 22,206 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #518.

Blackstone Inc first reported a position in PLRX in Q3 2022 and has held it in 16 quarters since. The position peaked at $433K in Q1 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Blackstone Inc held 22,206 shares of Pliant Therapeutics worth $25.3K as of Q2 2026.
Blackstone Inc left its Pliant Therapeutics share count unchanged in Q2 2026.
Pliant Therapeutics made up ﹤0.01% of Blackstone Inc's portfolio in Q2 2026, its #518 holding.
Blackstone Inc first reported a position in Pliant Therapeutics in Q3 2022 and has held it in 16 quarters since.
Blackstone Inc's Pliant Therapeutics position peaked at $433K in Q1 2023.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.